全部 标题 作者 关键词 摘要
DOI: 10.3971/j.issn.1000-8578.2019.18.1561
Keywords: A Meta-analysis,Value of 18F-FDG PET/CT in Evaluating Chemotherapeutic Effect of Diffuse Large B Cell Lymphoma Patients with Different CD5 Expression,Advances in Prognostic Value of Peripheral Blood Inflammatory Indexes in Non-small Cell Lung Cancer,Efficacy and Prognostic Factors of Docetaxel Rechallenge on Metastatic Castrationresistant Prostate Cancer Patients,Comparison of Survival and Postoperative Complication of Stage Ⅰb2-Ⅱa2 Cervical Cancer Patients Among Three Kinds of Therapeutic Regimens,Cholesterol: A Predictor of Risk and Prognosis of Breast Cancer,Progress on Comprehensive Treatment of Nasopharyngeal Cancer,Predictive Value of Preoperative Hematologic Inflammatory Markers in Prognostic of Glioma Patients,Clinical Treatment and Prognosis of 101 Patients with Small Cell Neuroendocrine Carcinoma of Cervix
Full-Text Cite this paper Add to My Lib
摘要 目的 探讨原发甲状腺淋巴瘤(PTL)的临床表现、病理特点、治疗方案及预后,以期为该病的诊断和治疗提供参考。方法 回顾性分析经病理证实的13例PTL患者的临床病理特征、诊断治疗及预后资料。 结果 所有患者均为B细胞非霍奇金淋巴瘤,其中结外边缘区淋巴瘤3例,弥漫大B细胞淋巴瘤10例;早期(Ⅰ~Ⅱ期)10例,晚期(Ⅲ~Ⅳ期)3例;除1例患者仅手术切除外,其余均进行了多药化疗或联合局部放疗;13例患者中位生存时间99.5(22~250)月,随访期超过5年的10例患者5年生存率为100%。结论 PTL发病率低,以甲状腺结节为主要症状起病,半数以上可伴有桥本氏甲状腺炎,病理类型以B细胞非霍奇金淋巴瘤为主,CHOP方案为主的化疗对绝大多数患者有效且均有较好的预后
Full-Text
Contact Us
service@oalib.com
QQ:3279437679
WhatsApp +8615387084133